BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1453768)

  • 1. Clinical significance of monoclonal proteins in chronic lymphocytic leukemia.
    Bernstein ZP; Fitzpatrick JE; O'Donnell A; Han T; Foon KA; Bhargava A
    Leukemia; 1992 Dec; 6(12):1243-5. PubMed ID: 1453768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.
    Dhodapkar M; Tefferi A; Su J; Phyliky RL
    Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
    Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
    Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of serum albumin in chronic lymphocytic leukemia.
    Levis A; Ficara F; Marmont F; De Crescenzo A; Resegotti L
    Haematologica; 1991; 76(2):113-9. PubMed ID: 1937168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of serum immunoglobulin paraprotein in chronic lymphocytic leukemia].
    Yang S; Zou ZJ; Li YY; Zhang LN; Han TT; Fan L; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):795-800. PubMed ID: 23384896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].
    Ramont L; Ngoc PT; Pignon B; Maquart FX
    Ann Biol Clin (Paris); 2002; 60(5):565-70. PubMed ID: 12368142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial.
    Böttcher S; Ritgen M; Fischer K; Stilgenbauer S; Busch RM; Fingerle-Rowson G; Fink AM; Bühler A; Zenz T; Wenger MK; Mendila M; Wendtner CM; Eichhorst BF; Döhner H; Hallek MJ; Kneba M
    J Clin Oncol; 2012 Mar; 30(9):980-8. PubMed ID: 22331940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
    Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
    Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemia.
    Hansen DA; Robbins BA; Bylund DJ; Piro LD; Saven A; Ellison DJ
    Am J Clin Pathol; 1994 Nov; 102(5):580-5. PubMed ID: 7942620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.
    Molica S; Digiesi G; Mirabelli R; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Morabito F; Neri A; Baldini L; Ferrarini M
    Eur J Haematol; 2009 Sep; 83(3):208-14. PubMed ID: 19459926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).
    Faderl S; Keating MJ; Do KA; Liang SY; Kantarjian HM; O'Brien S; Garcia-Manero G; Manshouri T; Albitar M
    Leukemia; 2002 Jun; 16(6):1045-52. PubMed ID: 12040436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients.
    Butrym A; Majewski M; Dzietczenia J; Kuliczkowski K; Mazur G
    Leuk Res; 2012 Jul; 36(7):876-80. PubMed ID: 22333038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
    Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    Martin W; Abraham R; Shanafelt T; Clark RJ; Bone N; Geyer SM; Katzmann JA; Bradwell A; Kay NE; Witzig TE
    Transl Res; 2007 Apr; 149(4):231-5. PubMed ID: 17383597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.